Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Hartman

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Clinical Investigation|September 1, 1994
Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone releaseM L Hartman, S M Pincus, M L Johnson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 8, 1999
Validity of methods of body composition assessment in young and older men and womenJ L Clasey, J A Kanaley, L Wideman, et al.
Journal of Dairy Science|August 21, 2010
Evaluation of a biological risk management tool on large western United States dairiesD A Moore, D A Leach, D Bickett-Weddle, et al.
Metabolism: Clinical and Experimental|September 1, 1990
Physiological role of somatostatin on growth hormone regulation in humansM O Thorner, M L Vance, M L Hartman, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young menS E Kirk, B J Gertz, S H Schneider, et al.
Diabetes, Obesity & Metabolism|June 7, 2016
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3R M Bergenstal, H Lunt, E Franek, et al.
Diabetes, Obesity & Metabolism|June 29, 2016
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trialM J Davies, D Russell-Jones, J-L Selam, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13J L Stock, M R Warth, B T Teh, et al.
Diabetes, Obesity & Metabolism|October 11, 2016
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetesK Cusi, A J Sanyal, S Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjectsI M Chapman, M A Bach, E Van Cauter, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Clinical Investigation|September 1, 1994
Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone releaseM L Hartman, S M Pincus, M L Johnson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 8, 1999
Validity of methods of body composition assessment in young and older men and womenJ L Clasey, J A Kanaley, L Wideman, et al.
Journal of Dairy Science|August 21, 2010
Evaluation of a biological risk management tool on large western United States dairiesD A Moore, D A Leach, D Bickett-Weddle, et al.
Metabolism: Clinical and Experimental|September 1, 1990
Physiological role of somatostatin on growth hormone regulation in humansM O Thorner, M L Vance, M L Hartman, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young menS E Kirk, B J Gertz, S H Schneider, et al.
Diabetes, Obesity & Metabolism|June 7, 2016
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3R M Bergenstal, H Lunt, E Franek, et al.
Diabetes, Obesity & Metabolism|June 29, 2016
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trialM J Davies, D Russell-Jones, J-L Selam, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13J L Stock, M R Warth, B T Teh, et al.
Diabetes, Obesity & Metabolism|October 11, 2016
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetesK Cusi, A J Sanyal, S Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjectsI M Chapman, M A Bach, E Van Cauter, et al.
Pageof 5